21st Virtual PCF Pharma & Med Device Ethics & Compliance Congress Features Annual CCO Fireside Chat & New Interactive Virtual Broadcast Platform
  • Virtual Online Video Event Live and 6 Months Access to Video Archive
  • Sponsored by the Pharmaceutical Compliance Forum
  • Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
  • November 4 - 6, 2020
  • www.PharmaCongress.com

PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com
SPEAKER PRESENTATION PROPOSALS
Speaker/Presentation Proposals for the Virtual 21st Anniversary Pharma Congress May Be Submitted Through Our Online Form
- Click Here -

EARLY BIRD REGISTRATION DISCOUNTS NOW AVAILABLE
Early bird registration discounts now available with special PCF rates. Rates are up to $1,000 less than major competing events.
- Click here to register.

NETWORK VIA OUR ADVANCED VIRTUAL BROADCAST AND NETWORKING PORTAL

FEATURING THE ANNUAL CHIEF COMPLIANCE OFFICER FIRESIDE CHAT WITH

Dennis K. Barnes, JD CPA
Vice President, Global Governance, Risk & Compliance, Mayne Pharma, Former Vice President, Compliance & Risk Management, Global Compliance Officer, PAREXEL International, Raleigh-Durham, NC

Mark Graves, JD, MBA
Senior Vice President and Chief Compliance Officer, MiMedx, Former Director, Global Patient Experience & Value, UCB; Former Senior Director, Pharmaceutical Products Division, Abbott; Marietta, GA

Nancy A. Grygiel, JD
Senior Vice President, Chief Compliance Officer, Amgen, Former VP Compliance, Corporate & International, Allergan, Former Senior Director Global Compliance, Mylan, Newbury Park, CA

John Knighton, JD
Chief Compliance Officer, TherapeuticsMD, Former Vice President, Head of Global Compliance, Orexigen Therapeutics, Boca Raton, FL

Tara R. Shewchuk, LLB
Vice President and Deputy, Office of Ethics & Compliance, Medtronic, Former Senior Director, Ethics and Compliance, Abbott (now AbbVie), Former VP, Chief Compliance, Privacy & Security Officer, Resurrection Health Care (now Ascension/AMITA), Minneapolis, MN

Tom Gregory, MBA
Partner, Forensic & Integrity Services, EY, Atlanta, USA (Moderator)

WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- SEPTEMBER 16, 2020: The 21st Anniversary Pharmaceutical and Medical Device Compliance Congress, www.PharmaCongress.com, to be held November 4 - 6, 2020 as a fully virtual event, today announced the conference dates and a call for presentation proposals.

KEYNOTE SPEAKERS

Craig Carpenito, JD
United States Attorney, US Attorney’s Office, District of New Jersey, Former Senior Counsel, Northeast Regional Office, US Securities and Exchange Commission, Newark, NJ

Susan Dentzer
Visiting Fellow, Duke-Margolis Center for Health Policy, Former Editor in Chief, Health Affairs, Former Health Correspondent, PBS NewsHour, Washington, DC

Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion (OPDP), US Food and Drug Administration, Silver Spring, MD

Matthew J. Lash, JD
Trial Attorney, Consumer Protection Branch, US Department of Justice, Washington, DC

Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC

Gregg Shapiro, JD
Assistant US Attorney and Chief, Affirmative Civil Enforcement Unit, US Attorney's Office, District of Massachusetts, US Department of Justice, Boston, MA

FEATURING THE ANNUAL INVITATION-ONLY CHIEF COMPLAINCE OFFICER ROUNDTABLE
November 4, 2020; Invitation-only; No Cost. CCOs interested in attending may contact Debra Scanlon, Administrator, Pharmaceutical Compliance Forum at info@pharmacomplianceforum.org.
ANNUAL ADVAMED UPDATE BY

Christopher L. White, JD
Chief Operating Officer & General Counsel, Advanced Medical Technology Association (AdvaMed), Washington, DC
ANNUAL PHRMA UPDATE BY

Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA, Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Washington, DC

CONGRESS HIGHLIGHTS
  • New content, optimized for online learning, focused on new regulatory developments and managing ethics and compliance programs during the COVID 19 pandemic
  • Engage with faculty through polling, Q&A sessions, chat and direct video messaging
  • Network in real time with other attendees through direct attendee to attendee and group video messaging
  • Live and curated sessions streamed directly to you through our easy to navigate virtual platform
  • Access to an extensive video archive of past Congress presentations providing a context for the evolution of the compliance professions and the legal and regulatory setting
  • Virtual exhibit hall featuring innovative solutions, products and services with opportunity to directly contact exhibitors for further information

FEATURING THE ANNUAL CHIEF COMPLIANCE OFFICERS ROUNDTABLE

Dennis K. Barnes, JD CPA
Vice President, Global Governance, Risk & Compliance, Mayne Pharma, Former Vice President, Compliance & Risk Management, Global Compliance Officer, PAREXEL International, Raleigh-Durham, NC

Mark Graves, JD, MBA
Senior Vice President and Chief Compliance Officer, MiMedx, Former Director, Global Patient Experience & Value, UCB; Former Senior Director, Pharmaceutical Products Division, Abbott; Marietta, GA

Nancy A. Grygiel, JD
Senior Vice President, Chief Compliance Officer, Amgen, Former VP Compliance, Corporate & International, Allergan, Former Senior Director Global Compliance, Mylan, Newbury Park, CA

John Knighton, JD
Chief Compliance Officer, TherapeuticsMD, Former Vice President, Head of Global Compliance, Orexigen Therapeutics, Boca Raton, FL

Tara R. Shewchuk, LLB
Vice President and Deputy, Office of Ethics & Compliance, Medtronic, Former Senior Director, Ethics and Compliance, Abbott (now AbbVie), Former VP, Chief Compliance, Privacy & Security Officer, Resurrection Health Care (now Ascension/AMITA), Minneapolis, MN

Tom Gregory, MBA
Partner, Forensic & Integrity Services, EY, Atlanta, USA (Moderator)

AND A ROUNDTABLE ON IMPLEMENTING EQUITY, DIVERSITY AND INCLUSION BY

Michael R. Clarke, CCEP
Vice President, Global Chief Compliance Officer, ConvaTec, Former VP, Corporate Compliance, Indivior, Former VP, Ethics & Compliance, Americas, Actavis, Former VP & Compliance Officer, Biomet Spine & Bone Healing Technologies, Bridgewater, NJ

Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Former VP Healthcare Compliance & Privacy, Johnson & Johnson, Former Global Chief Compliance Officer and Corporate VP, Biomet, Chicago, IL

Jill Fallows Macaluso
Corporate Vice President, Chief Ethics, Compliance & Privacy Officer, NovoNordisk, Princeton, NJ

Robert A. Ladd, JD
Vice President, Global Head Integrity & Compliance, Novartis, Oncology; Former General Counsel, GE Healthcare; Former Global Head of Compliance Training, Goldman Sachs; Former Senior Corporate Counsel, Pfizer; New York, NY

Latarsha Stewart, JD, MS
Vice President, Head of Compliance, Servier Pharmaceuticals; Former Head of Compliance, Global Oncology Business Unit, Takeda Oncology; Boston, MA

FEATURED FACULTY

Khelin N. Aiken, JD
Partner, Baker & McKenzie LLP, Former Regulatory Counsel, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), Washington, DC

Sergio Alegre, JD
Vice President, Global Compliance, Osmotica, Former Executive Director Compliance, Pacira, Bridgewater, NJ

John T. Bentivoglio, JD
Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice; Washington, DC

Richard Bistrong, MA
Chief Executive Officer, Front-Line Anti-Bribery LLC, Contributing Editor, FCPA Blog, Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ, Former Cooperating Witness, City of London Police, HMRC and CPS, UK, New York, NY

Christie Camelio
Chief Compliance, Ethics & Risk Management Officer, TG Therapeutics, Former, Vice President, Deputy Global Chief Compliance Officer, Celgene, New York, NY

Cynthia Cetani
Chief Integrity & Compliance Officer, Indivior, Former Group Integrity & Compliance, Head, Compliance Operations, Novartis International AG, Richmond, VA

Katherine Chaurette, MS, JD
Vice President Healthcare Law and Compliance, Blueprint Medicines, Former Sr. Director, Regulatory and Commercial Law, Regeneron, Former VP, Legal, Head of Health Law, Regulatory, Market Access, Marketed and Launch Products, Sanofi, Jamaica Plain, MA

Masha Chestukhin, MSJ
Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme, Former Senior Manager NA Compliance, Sanofi, Jamaica Plain, MA

Yvonne Clark, JD
Corporate Compliance Counsel, Spark Therapeutics, Former Commercial Counsel, Merck, Philadelphia, PA

Ethan Davis, JD
Partner, King & Spalding LLP, Former Acting Assistant Attorney General, Civil Division, US Department of Justice, Washington, DC

Kimberly Davis, JD
Chief Compliance Officer, Kaleo, Richmond, VA

Anisa Dhalla
Global Chief Compliance Officer, UCB, Inc., Former Manager, Regulatory Affairs, Solvay and Mikart, Atlanta, GA

Sarah diFrancesca, JD
Partner, Dinsmore & Shohl LLP, Cincinnati, OH

Tara D'Orsi, JD
Executive Vice President, Chief Compliance Officer, and General Counsel, Kyowa Kirin North America, Former Senior Counsel, Reliant Pharmaceuticals, New York, NY

Margaret Feltz, MA, JD
Vice President, Ethics & Compliance, Purdue Pharma, Former Compliance Counsel, Boehringer Ingelheim, Stamford, CT

Christine Fiore, MBA
Executive Director, Ethics and Commercial Compliance, Boehringer Ingelheim; Former Group Director Ethics and Compliance, Smith & Nephew; Ridgefield, CT

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.; New York, NY

Virginia “Ginny” A. Gibson, JD
Partner, Hogan Lovells LLP, Former First Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA

Betania Glorio, LLM
Global Compliance Officer, Healthcare, Merck KGaA, Former Senior Director, Legal and Compliance EMEA, Horizon, Raptor and Onyx, Darmstadt, Germany

Thomas Goimarac, MBA, CHFP
Managing Consultant, Berkeley Research Group, LLC (BRG), Phoenix, AZ

Michael Hercz, JD
Senior Vice President and General Counsel, Sentynl, Former Vice President, Law & Chief Compliance Officer, Victory Pharma, Former Executive Director, Enterprise Risk Management, Amgen, Solana Beach, CA

Briannon Irwin, JD
Senior Managing Consultant, Berkeley Research Group (BRG); Former Judicial Law Clerk, The Supreme Court of Pennsylvania; Washington, DC

Michael Joachim, JD
Head of Ethics & Business Integrity, Specialty Care, Sanofi Genzyme, Cambridge, MA

Catherine Healy Kanzler, JD
Head, Global Compliance Operations, Olympus Corporation of the Americas, New York, NY

Ben Kaye-Smith
Senior Vice President Ethics, Risk & Compliance, AveXis, Former Corporate Health Safety Environment Manager, Former Global Head Integrity & Compliance Risk Review & Prevention, Novartis, Switzerland

Keith Korenchuk, MPH, JD
Vice President and Chief Compliance Officer, DH Diagnostics, a Danaher Company, Chevy Chase, MD

Kirt Kraeuter, MGA
Senior Director, Corporate Compliance at Moderna, Former European Compliance Director, Otsuka, Former, Executive Director, Worldwide Compliance Committee & Monitoring, Bristol-Myers Squibb, Yardley, PA

Stephanie Kurteff, JD
Head of Compliance, Medicines360, Former Director of Healthcare Compliance, SI-BONE, Inc., Former Associate Director, Office of Ethics & Compliance, Pharmacyclics, San Francisco, CA

Jodi Lindsey, JD
Vice President, Healthcare Counsel and Head of U.S. Compliance, Alkermes, Former Associate Director, Commercial Compliance, Biogen, West Roxbury, MA

Kari Loeser, JD
US Healthcare Compliance Officer, Relypsa, Former Senior Counsel, Jazz Pharmaceuticals, Former Senior Manager, Genentech, Redwood City, CA

Joshua Marks, JD
Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim, Former Executive Division Counsel, Corporate Compliance Officer & Asst. Secretary, Ben Venue Laboratories, Ridgefield, CT

Jane Mathews, LLM, JD
Vice President and Chief Compliance Officer, Lexicon, Former Assistant General Counsel, Sunovion, Former Senior Counsel-Managing Attorney - Head of Litigation, Hoffmann-La Roche, Ringwood, NJ

Heather McCollum, JD, MHA, CCEP-I
Director, Compliance, Shionogi, Florham Park, NJ

Jennifer McGee, JD
Vice President & Chief Compliance Officer, Otsuka America Pharmaceutical, Rockville, MD

Jenny McVey, MS, PHD
Compliance Risk Strategy & Management, Novo Nordisk, Compliance Lead, Hands International, Editorial Board Member, Policy & Medicine Compliance Update, Princeton, NJ

Patrick Mooty
Head of Compliance, Sumitomo Dainippon Pharma America, Marlborough, MA

Gregory S. Moss, LLB
Executive Vice President, General Counsel and Corporate Secretary, Chief Compliance Officer, Kadmon Holdings, New York, NY

Kristin Mykulak, JD
Assistant General Counsel, Litigation & Compliance, Dr. Reddy's Laboratories, Princeton, NJ

Amy Pawloski
President, Strategic Versatility; Former Global Compliance Operations Officer, Endo, Phoenixville, PA

Veleka Peeples-Dyer, JD
Partner and Chair, North America Food and Drug, Administration (FDA) Practice Group, Baker & McKenzie LLP, Washington, DC

Brad Powers, JD
General Counsel and Chief Compliance Officer, Lumos Pharma, Former General Counsel and Chief Compliance Officer, Office of the CEO, NewLink Genetics, Des Moines, IA

Kristin Rand, JD, MA
Head, Corporate Compliance and Global Risk Officer, Moderna, Former Vice President & Chief Compliance Officer, Seattle Genetics, Boston, MA

Kelly N. "Nikki" Reeves, MPA, JD
Partner and Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding LLP, Washington, DC

Kevin Ryan, MS, JD
Vice President, Chief Compliance Officer, ACADIA, Former Director, Ethics & Compliance, Novo Nordisk, San Diego, CA

Jennifer Santos, MPH, JD
Head of Global Corporate Compliance Operations, Vertex Pharmaceuticals, Former Associate General Counsel, Tufts Medical Center, Boston, MA

Jonathan Sayegh, JD
Associate Director, Compliance & Ethics, Sunovion, Marlborough, MA

Eric Siegel, MBA, JD
Vice President, Head of Compliance US, Idorsia Pharmaceuticals US Inc.; Former Chief Compliance Officer, Jazz Pharmaceuticals; Former Senior Investigator, Office of the Inspector General, City of Philadelphia; Philadelphia, PA

Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA

Melissa Tearney, JD
Government Enforcement Partner, Choate, Hall & Stewart, Boston, MA

Bryan Timer, MA
Director, Data Analytics & Transparency, Merck and Co, Inc., Kenilworth, NJ

Elizabeth Weiss, JD
Assistant General Counsel, Pfizer, Former Research Chemist, Ortho Clinical Diagnostics, Peapack, NJ

Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Editor, Life Science Compliance Update, Senior Fellow & Adjunct Professor, Life Sciences Compliance, Mitchell Hamline School of Law, West Chester, PA

Amy Yuda, MSJ, CHC, CQA, CCEP
Compliance Officer, PolarityTE, Salt Lake City, UT

2020-2021 GLOBAL PHARMA/MED DEVICE ETHICS & COMPLIANCE CONGRESSES

VIRTUAL TWENTY-FIRST ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Virtual Online Video Event Live and Archived
Sponsored by Pharmaceutical Compliance Forum
Media Partners: Harvard Health Policy Review, Health Affairs and Policy & Medicine Compliance Update
November 4 - 6, 2020
www.PharmaCongress.com
VIRTUAL FOURTEENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE ETHICS & COMPLIANCE CONGRESS
Virtual Online Video Event Live and Archived
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partner: Policy & Medicine Compliance Update
February 22 - 25, 2021
www.International PharmaCongress.com

SPONSORED BY

The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 70+ distinguished researched-based pharmaceutical manufacturers and biotech companies. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effect corporate compliance programs.


CO CHAIRS

Indrani Franchini, JD
Executive Vice President Chief Compliance Officer, Alexion Pharmaceuticals, New York, NY
(PCF CO-Chair)


Jeffrey Kawalek, MBA
Deputy Chief Compliance Officer, Jazz Pharmaceuticals, Inc., Philadelphia, PA
(PCF Chair)


Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi US, Bridgewater, NJ (PCF Co-chair)


Ann Marie Tejcek
Senior Director, Chief Compliance Officer North America, Eli Lilly, Indianapolis, IN
(PCF CO-Chair)


Donna White, CCEP
Vice President, Contracts & Compliance Chiesi, Cary, NC
(PCF CO-Chair)


Joe Zimmerman
Vice President, Chief Compliance Officer & Privacy Officer, Ferring Pharmaceuticals, Parsippany, NJ
(PCF Co-chair)

MEDIA PARTNERS:






GRANTORS:
GOLD


SILVER




BRONZE


















STAY CONNECTED


Tweet using #PharmaCongress

PAST GLOBAL PHARMA COMPLIANCE CONGRESSES

2007 - Brussels


2008 - Paris


2009 - Rome


2010 - Berlin


2011 - Istanbul


2011 - Singapore


2012 - Budapest


2012 - Shanghai







CONGRESS REGISTRATION
For Congress registration information, visit https://www.pharmacongress.com/registration/, email reginfo@hcconferences.com, or call 800-503-7419.

CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.